Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is an integrated beauty and wellness company whose news flow centers on product innovation, device launches, financial performance and global expansion. The company’s public updates highlight its focus on beauty and wellness device systems, nutritional products and anti-aging brands sold through a dynamic affiliate opportunity platform in nearly 50 markets worldwide.
News about Nu Skin often includes announcements of quarterly and full-year financial results, where management discusses revenue, earnings per share, regional performance and non-GAAP metrics such as constant-currency revenue change and adjusted EPS. These releases are frequently accompanied by conference call and webcast details, giving context on operating trends, segment results for the Nu Skin and Rhyz businesses, and guidance ranges.
Another key category of NUS news involves product and technology developments. Recent communications have featured the introduction of Prysm iO, an AI-powered intelligent nutritional wellness platform that measures carotenoid levels through a non-invasive finger scan and connects with Prysm-certified supplements. Nu Skin also issues updates about its portfolio of beauty and wellness device systems and recognition from third parties, such as rankings from Euromonitor International Ltd. for at-home beauty and wellness device systems.
Investors and followers of NUS can also expect news on strategic initiatives, including pre-market and launch activities in emerging markets like India, and commentary on regional trends such as growth in Latin America. Conference participation, moderated fireside chats and strategy discussions at industry events are additional sources of information on the company’s direction. Bookmark this page to monitor Nu Skin’s earnings releases, device and product announcements, geographic expansion updates and other material developments reflected in its news coverage.
Nu Skin (NYSE: NUS) launched Prysm iO, an AI-powered, fingertip skin scanner that measures carotenoid antioxidant levels in 15 seconds and is available in the U.S. for $375. The device uses patent-pending Spectral Rai Technology and a database of >20 million scans.
Clinical validation (97 participants) showed strong correlation with blood serum (R² = 0.75–0.77); Prysm iO provides a Nutrition Health Score and integrates with Nu Skin supplements.
Nu Skin Enterprises (NYSE: NUS) appointed Chelsea Lantz as interim Chief Financial Officer, effective March 20, 2026, after James Thomas stepped down to pursue an outside opportunity. The board has started a formal search for a permanent CFO while Lantz will continue cost-improvement and operational performance efforts.
Lantz joined Nu Skin in 2011, served as corporate controller since 2023, and led initiatives that the company says produced a significant year-over-year increase in EPS. She previously worked at PricewaterhouseCoopers and holds a Master of Accounting from Utah State University.
Nu Skin (NYSE:NUS) appointed Chayce Clark as chief operating officer, effective March 9, 2026, while he retains his chief legal officer role.
Clark will lead revenue performance and end-to-end operations, overseeing global sales, product innovation, technology platforms, brand programs and legal services across nearly 50 markets, and will support the Prysm iO rollout and India expansion.
NU Skin Enterprises (NYSE: NUS) reported FY25 results with $370.3M revenue, adjusted net income $14.5M, and adjusted EPS $0.29. Results trailed Stonegate estimates modestly but hit the high end of EPS guidance.
Rhyz contributed $48.52M (Manufacturing $42.45M; Rhyz Other $6.07M). Nu Skin posted 77.6% gross margin and selling expense improved to 40.8% of the core business. Management cited margin expansion, a one-time tax benefit, and expansion into India; Prism iO rollout and India opening timelines target 1H26 pre-launch and full opening in 2H26. FY26 EPS guidance midpoint: $1.00.
Nu Skin (NYSE: NUS) reported Q4 2025 revenue of $370.3M (down 16.9%) and full-year 2025 revenue of $1.49B (down 14.3%). Fiscal 2025 EPS was $3.18 with more than 50% earnings growth year-over-year. Q4 gross margin improved to 70.7% and operating margin was 6.3%.
The company provided Q1 2026 revenue guidance of $320–$340M and full-year 2026 revenue guidance of $1.35–$1.50B with EPS of $0.80–$1.20. Management highlighted Prysm iO device rollout and India pre-market work as growth initiatives.
Nu Skin Enterprises (NYSE: NUS) declared a quarterly cash dividend of $0.06 per share. The dividend is payable on Mar. 11, 2026 to shareholders of record on Feb. 27, 2026.
This notice communicates the declared per-share amount, record date, and payment date for investors.
Nu Skin (NYSE: NUS) announced the relaunch of Dr. Joseph Chang’s bestselling book The Aging Myth with 15 years of additional research on measurable biology and cellular wellness.
The updated edition links expanded chapters on cellular resilience, oxidative stress, and measurable biomarkers to Nu Skin’s Prysm iO platform and ageLOC technologies. The digital edition is available today for $9.99 on major retailers.
Stonegate Capital Partners attended the ICR 2026 conference in Dallas on January 14, 2026, where it moderated a fireside chat with Nu Skin (NASDAQ: NUS). Stonegate also attended presentations from LifeVantage (LFVN), USANA (USNA), Beachbody (BODI) and Strauss Group (STRS), and observed an RSM panel on "cutting through the AI hype." The release notes common themes across retail, hybrid and DTC go-to-market models in nutrition, beauty and wellness sectors and points readers to the full announcement for images and bios.
Nu Skin Enterprises (NYSE:NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, Feb. 12, 2026. The management team will host a conference call the same day at 5:00 p.m. ET to discuss recent results and upcoming business initiatives. A live webcast of the call and the financial presentation will be available on the company investor relations site at ir.nuskin.com. A replay will remain available through Thursday, Feb. 26, 2026.
Nu Skin (NYSE: NUS) announced that president and CEO Ryan Napierski will participate in a moderated fireside chat at the ICR Conference on Monday, Jan. 12, 2026 to discuss company strategy and the state of the business. The discussion will cover 2026 plans to launch the Prysm iO intelligent wellness device and growth opportunities in emerging markets, including India. The event will be webcast live at 1:30 p.m. ET, with an archive available on the company investor relations site through Monday, Jan. 26, 2026.